Merck & Co., Inc.
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Directory totals · amendments may overlap
Directory updated .
Individual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Contribution records are temporarily unavailable for this selection; this does not mean there are no contributions. Try again.
Open full contribution table →Loading company overview…
These immutable labels appeared in FEC filings and are grouped under Merck & Co., Inc..
The employer directory provides this indexed total. Its records have not been resolved to their latest amendments, so it may include superseded entries. Money-network details are not available for this view yet.
The shared contribution publication is not available for this selection. This does not mean there are no matching records.
Try againData: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Industry classification summary
Merck & Co., Inc. is a global biopharmaceutical company that develops and manufactures prescription medicines and vaccines. It is explicitly identified in the research as the entity referred to by the contributor Kenneth C. Frazier and is distinct from the German Merck KGaA in North American markets.
AI-generated classification based on saved sources
View source